WO2023002433 - COMPOSITIONS AND VACCINES FOR TREATING AND/OR PREVENTING CORONAVIRUS VARIANT INFECTIONS AND METHODS OF USING THE SAME
National phase entry:
Publication Number
WO/2023/002433
Publication Date
26.01.2023
International Application No.
PCT/IB2022/056759
International Filing Date
21.07.2022
Title **
[English]
COMPOSITIONS AND VACCINES FOR TREATING AND/OR PREVENTING CORONAVIRUS VARIANT INFECTIONS AND METHODS OF USING THE SAME
[French]
COMPOSITIONS ET VACCINS POUR LE TRAITEMENT ET/OU LA PRÉVENTION D'INFECTIONS À VARIANTS DE CORONAVIRUS ET MÉTHODES D'UTILISATION DE CEUX-CI
Applicants **
ENGENEIC MOLECULAR DELIVERY PTY LTD
Inventors
BRAHMBHATT, Himanshu
MACDIARMID, Jennifer
Priority Data
63/224,838
22.07.2021
US
17/480,073
20.09.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
MOIP
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3072 | |
| EPO | Filing, Examination, Granting | 16181 | |
| Japan | Filing, Examination, Granting | 2261 | |
| South Korea | Filing, Examination, Granting | 1759 | |
| USA | Filing, Examination, Granting | 6390 |
Total:
29,663
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present disclosure is directed to compositions and methods useful for treating, as well as vaccinating against, SARS-CoV-2 viral infections, including SARS-CoV-2 variant viral infections.[French]
La présente invention concerne des compositions et des méthodes servant au traitement, ainsi qu'à la vaccination contre des infections virales à SARS-CoV-2, y compris des infections virales à variants du SARS-CoV-2.